The frequencies of NAD(P)H quinone oxidoreductase (NQO1) variant allele in Israeli ethnic groups and the relationship of NQO1*2 to adult acute myeloid leukemia in Israeli patients

Haematologica

Volumn 91, Issue 7, 2006, Pages 956-959

  Malik, Elad ^a   Bar Cohen, Sara ^b   Sahar, Dvorah ^c   Dann, Eldad J ^c   Rund, Deborah ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Chromosomal abnormalities; Myeloid leukemia; NAD(P)H:quinone oxidoreductase; Predisposing polymorphisms

Indexed keywords

OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE QUINONE OXIDOREDUCTASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE QUINONE OXIDOREDUCTASE 2; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLELE; ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNOLOGY; FEMALE; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE;

ACUTE DISEASE; EPIDEMIOLOGY, MOLECULAR; GENE FREQUENCY; ISRAEL; LEUKEMIA, MYELOID; NAD(P)H DEHYDROGENASE (QUINONE); VARIATION (GENETICS);

EID: 33745770600     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Traver RD, Siegel D, Beau HD, Phillips RM, Gibson NW, Franklin WA, et al. Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). Br J Cancer 1997;75: 69-75.
2. Nebert DW, Roe AL, Vandale SE, Bingham E, Oakley GG. NAD(P)H: quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review. Genet Med 2002;4:62-70.
3. Lan Q, Zhang L, Li G, Vermeulen R, Weinberg RS, Dosemeci M, et al. Hematotoxicity in workers exposed to low levels of benzene. Science 2004; 306:1774-6.
4. Rothman N, Smith MT, Hayes RB, Traver RD, Hoener B, Campleman S, et al. Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C→T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res 1997;57:2839-42.
5. Kim SY, Choi JK, Cho YH, Chung EJ, Paek D, Chung HW. Chromosomal aberrations in workers exposed to low levels of benzene: association with genetic polymorphisms. Pharmacogenetics 2004;14:453-63.
6. Bauer AK, Faiola B, Abernethy DJ, Marchan R, Pluta LJ, Wong VA, et al. Genetic susceptibility to benzene-induced toxicity: role of NADPH: quinone oxidoreductase-1. Cancer Res 2003;63:929-35.
7. Larson RA, Wang Y, Banerjee M, Wiemels J, Hartford C, Le Beau MM, et al. Prevalence of the inactivating 609C→T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood 1999;94:803-7.
8. Naoe T, Takeyama K, Yokozawa T, Kiyoi H, Seto M, Uike N, et al. Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res 2000;6:4091-5.
9. Smith MT, Wang Y, Kane E, Rollinson S, Wiemeis JL, Roman E, et al. Low NAD(P)H:quinone oxidoreductase I activity is associated with an increased risk of acute leukemia in adults. Blood 2001;97:1422-6.
10. Seedhouse C, Bainton R, Lewis M, Harding A, Russell N, Das-Gupta E. The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia. Blood 2002;100:3761-6.
11. Rund D, Krichevsky S, Bar-Cohen S, Goldschmidt N, Kedmi M, Malik E, et al. Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients. Leukemia. 2005;19:1919-28.
12. Kedmi M, Cohen SB, Rund D. Polymorphisms in drug metabolism/disposition genes and increased susceptibility to adult de novo AML: MDR1 and CYP3A4. Blood 2004;104 Suppl 1:572a[abstract].
13. Kelsey KT, Ross D, Traver RD, Christiani DC, Zuo ZF, Spitz MR, et al. Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy. Br J Cancer 1997;76:852-4.
14. Reynolds WF, Chang E, Douer D, Ball ED, Kanda V. An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia. Blood 1997;90:2730-7.
15. Morgan GJ, Smith MT. Metabolic enzyme polymorphisms and susceptibility to acute leukemia in adults. Am J Pharmacogenomics 2002;2:79-92.
16. Eguchi-Ishimae M, Eguchi M, Ishii E, Knight D, Sadakane Y, Isoyama K, et al. The association of a distinctive allele of NAD(P)H:quinone oxidoreductase with pediatric acute lymphoblastic leukemias with MLL fusion genes in Japan. Haematologica 2005; 90:1511-5.
17. Nebel A, Filon D, Weiss DA, Weale M, Faerman M, Oppenheim A, Thomas MG. High-resolution Y chromosomal haplotypes of Israeli and Palestinian Arabs reveal geographic substructure and substantial overlap with haplotypes of Jews. Hum Genet 2000; 107:630-41.